Clinical application of antimicrobial peptides (AMPs), as with conventional antibiotics, may be compromised by the development of bacterial resistance. This study investigated AMP resistance in methicillin resistant Staphylococcus aureus, including aspects related to the resilience of the resistant bacteria toward the peptides, the stability of resistance when selection pressures are removed, and whether resistance can be overcome by using the peptides with other membrane-permeabilising agents. Genotypically variant strains of S. aureus became equally resistant to the antibacterial peptides melittin and bac8c when grown in sub-lethal concentrations. Subculture of a melittin-resistant strain without melittin for 8 days lowered the minimal le...
The emergence of antibiotic resistance is a notorious problem worldwide. In the United States alone,...
Antimicrobial peptides (AMPs) provide a promising strategy against infections involving multidrug-re...
Antimicrobial peptides (AMPs) have been proposed as new class of antimicrobial drugs, following the ...
In this study, resistance towards antimicrobial peptides developed rapidly in MRSA, but resistance w...
Antimicrobial peptides (AMPs) have been proposed as a promising class of new antimicrobials partly b...
Mel4 is a novel cationic peptide with potent activity against Gram-positive bacteria. The current st...
Background: The clinical development of antimicrobial peptides (AMPs) is currently under evaluation ...
The global increasing problem of antibiotic resistance necessarily drives the pursuit and discovery ...
Antimicrobial peptides (AMPs) have been proposed as new class of antimicrobial drugs, following the ...
Staphylococcus aureus is a bacterium that mainly colonizes the nasal cavity and skin. To colonize th...
Antimicrobial peptides (AMPs) are at the front-line of host defense during infection and play critic...
AbstractStaphylococci are commensal bacteria living on the epithelial surfaces of humans and other m...
Cationic antimicrobial peptides (AMPs) are an intrinsic part of the human innate immune system. Over...
AbstractCationic antimicrobial peptides (AMPs) are an intrinsic part of the human innate immune syst...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
The emergence of antibiotic resistance is a notorious problem worldwide. In the United States alone,...
Antimicrobial peptides (AMPs) provide a promising strategy against infections involving multidrug-re...
Antimicrobial peptides (AMPs) have been proposed as new class of antimicrobial drugs, following the ...
In this study, resistance towards antimicrobial peptides developed rapidly in MRSA, but resistance w...
Antimicrobial peptides (AMPs) have been proposed as a promising class of new antimicrobials partly b...
Mel4 is a novel cationic peptide with potent activity against Gram-positive bacteria. The current st...
Background: The clinical development of antimicrobial peptides (AMPs) is currently under evaluation ...
The global increasing problem of antibiotic resistance necessarily drives the pursuit and discovery ...
Antimicrobial peptides (AMPs) have been proposed as new class of antimicrobial drugs, following the ...
Staphylococcus aureus is a bacterium that mainly colonizes the nasal cavity and skin. To colonize th...
Antimicrobial peptides (AMPs) are at the front-line of host defense during infection and play critic...
AbstractStaphylococci are commensal bacteria living on the epithelial surfaces of humans and other m...
Cationic antimicrobial peptides (AMPs) are an intrinsic part of the human innate immune system. Over...
AbstractCationic antimicrobial peptides (AMPs) are an intrinsic part of the human innate immune syst...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
The emergence of antibiotic resistance is a notorious problem worldwide. In the United States alone,...
Antimicrobial peptides (AMPs) provide a promising strategy against infections involving multidrug-re...
Antimicrobial peptides (AMPs) have been proposed as new class of antimicrobial drugs, following the ...